Literature DB >> 17845919

Echocardiography in patients with symptomatic intracranial stenosis.

Scott E Kasner1, Michael J Lynn, Bryon P Jackson, Patrick M Pullicino, Marc I Chimowitz.   

Abstract

BACKGROUND: Echocardiography is often performed in patients with stroke, even when alternative stroke causes are identified. We evaluated the use of echocardiography in patients with transient ischemic attack (TIA) or stroke caused by stenosis of a major intracranial artery.
METHODS: The Warfarin Versus Aspirin for Symptomatic Intracranial Disease (WASID) trial was a National Institutes of Health-funded, randomized, double-blind, multicenter clinical trial in which 569 patients with TIA or ischemic stroke attributed to angiographically proven 50% to 99% stenosis of a major intracranial artery were randomly assigned to warfarin or aspirin. Patients with unequivocal cardiac sources of embolism were excluded. The risk of ischemic stroke, myocardial infarction, and vascular death was compared among patients who had or did not have echocardiography performed before enrollment, and Cox proportional hazards models were used to determine whether echocardiographic abnormalities present in greater than 5% of patients were associated with these outcomes.
RESULTS: In all, 264 of 569 patients in WASID had echocardiograms; 37% were transesophageal. Of these 264 patients, 69 had subsequent ischemic stroke, myocardial infarction, or vascular death. Patients who underwent echocardiography had similar event rates to those who did not (P = .18). Common abnormalities identified on echocardiography were not associated with subsequent risk in this population.
CONCLUSIONS: Among patients with TIA or stroke caused by intracranial arterial stenosis, echocardiography appears to offer limited diagnostic and prognostic value.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17845919      PMCID: PMC2063439          DOI: 10.1016/j.jstrokecerebrovasdis.2007.07.002

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  10 in total

1.  Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis.

Authors:  Scott E Kasner; Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano; Harry J Cloft
Journal:  Circulation       Date:  2006-01-23       Impact factor: 29.690

2.  Accuracy of initial stroke subtype diagnosis. a decision analysis.

Authors:  S E Kasner; S E Kimmel
Journal:  Cerebrovasc Dis       Date:  2000 Jan-Feb       Impact factor: 2.762

3.  Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Scott E Kasner; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

4.  Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence.

Authors:  G W Petty; R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

5.  Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effectiveness analysis.

Authors:  R L McNamara; J A Lima; P K Whelton; N R Powe
Journal:  Ann Intern Med       Date:  1997-11-01       Impact factor: 25.391

Review 6.  Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S R Messé; I E Silverman; J R Kizer; S Homma; C Zahn; G Gronseth; S E Kasner
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

7.  Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke.

Authors:  Shigeru Fujimoto; Masahiro Yasaka; Ryoichi Otsubo; Hiroshi Oe; Kazuyuki Nagatsuka; Kazuo Minematsu
Journal:  Stroke       Date:  2004-04-29       Impact factor: 7.914

Review 8.  Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke.

Authors:  Malcolm R Macleod; Pierre Amarenco; Stephen M Davis; Geoffrey A Donnan
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

Review 9.  Cardiogenic brain embolism. Cerebral Embolism Task Force.

Authors: 
Journal:  Arch Neurol       Date:  1986-01

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

  10 in total
  1 in total

1.  Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.

Authors:  Imama A Naqvi; Ayeesha K Kamal; Hasan Rehman
Journal:  Cochrane Database Syst Rev       Date:  2020-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.